Dr. Razouki is the current Chief Business Development Officer of Kuwait Life Sciences Company (KLSC) where he is responsible for identifying new business opportunities for all KLSC subsidiary companies as well as sourcing investments opportunities for KLSC.
An Oral and Maxillofacial surgeon by training, Dr. Razouki has completed clinical rotations at the world’s top hospitals including New York Presbyterian Hospital of Columbia University Medical Center, Harlem Hospital, Cleveland University Hospital of Case Western Reserve University and Mass General Hospital of Harvard University.
A graduate of Columbia Business School, Dr. Razouki was recently selected by Stanford Medicine as part of a group of 20 global authors to write a chapter on digital health investing in the upcoming Springer published book: Digital Health: Scaling Healthcare to the World.
